Disease/Infection News

RSS

High-dose flu vaccine better than regular flu shot for frail, older adults of long-term care facilities

The high-dose flu vaccine is significantly better than the regular flu shot at boosting the immune response to the flu virus in frail, older residents of long-term care facilities, according to the results of a University of Pittsburgh School of Medicine study.

18 Dec 2014

Study offers insights into mechanisms of bacterial resistance to antimicrobial peptides

Antimicrobial peptides are a distinctive class of potent, broad-spectrum antibiotics produced by the body's innate immune system--the first line of defense against disease-causing microbes.

18 Dec 2014

R. Geigy Foundation recognizes scientific endeavours in neglected disease research, public health

The R. Geigy Foundation honours two scientific endeavours in neglected disease research and public health. It confers the R. Geigy Award (10'000 CHF) to the Laotian scientists Somphou Sayasone and the Jubilee Award (70'000) to the project "Connecting the Dots" proposed by the Swiss Tropical and Public Health Institute.

18 Dec 2014

COUNTDOWN research consortium focuses on neglected tropical diseases

The COUNTDOWN research consortium has been launched today following a £7 million grant allocation from the UK Department for International Development earlier in the year.

18 Dec 2014

New research finds that more frequent hugs protect people from stress, infection

Instead of an apple, could a hug-a-day keep the doctor away? According to new research from Carnegie Mellon University, that may not be that far-fetched of an idea.

18 Dec 2014

Scientists discover how certain gut bacteria can protect themselves, others from antibiotics

Scientists from the Institute of Food Research and the University of East Anglia have discovered how certain gut bacteria can protect themselves and others in the gut from antibiotics.

18 Dec 2014

EGPAF to receive $63 million UNITAID grant to improve early infant diagnosis of HIV programs

The Elizabeth Glaser Pediatric AIDS Foundation is pleased to announce that it has been selected by the UNITAID Executive Board to receive up to $63 million in funding to improve early infant diagnosis (EID) of HIV programs in nine African countries. This investment will pave the way for universal access to HIV testing and enable a ten-fold increase in HIV treatment, thus transforming the effort to end AIDS in children worldwide.

17 Dec 2014

Researchers identify 53 existing drugs that may block Ebola virus from entering human cells

Researchers found 53 existing drugs that may keep the Ebola virus from entering human cells, a key step in the process of infection, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and the National Institutes of Health, and published today in the Nature Press journal Emerging Microbes and Infections.

17 Dec 2014

New intervention combines social media with behavioral psychology to encourage more HIV testing

Social media such as Twitter and Facebook can be valuable in the fight against HIV in the United States, where research has demonstrated they can prompt high-risk populations to request at-home testing kits for the virus that causes AIDS, suggesting a way to potentially boost testing rates.

17 Dec 2014

Tufts University researchers report that extra vitamin E can protect against pneumonia

Extra vitamin E protected older mice from a bacterial infection that commonly causes pneumonia. Microbiologists and nutrition researchers from Tufts University report that the extra vitamin E helped regulate the mice's immune system.

17 Dec 2014

DNDi awarded USAID grant to develop new treatments for river blindness, elephantiasis

The Drugs for Neglected Diseases initiative has been awarded US$ 10 million by the United States Agency for International Development to develop new treatments for onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis) - the first-ever USAID grant for neglected tropical disease research and development (R&D).

17 Dec 2014

New study shows that people may inherit intestinal bacteria that cause inflammatory bowel disease

A new study by an international team of researchers shows for the first time that people may inherit some of the intestinal bacteria that cause Crohn's disease and ulcerative colitis, collectively know as inflammatory bowel disease (IBD). The study, recently published in Genome Medicine, also confirmed that antibiotics could worsen the imbalance in the gut microbes.

16 Dec 2014

CMC Biologics, OncoSynergy partner to develop novel potential treatment for Ebola

CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.

16 Dec 2014

CARLINA, Atlangram partner to develop antibiotics for osteoarticular infectious diseases

CARLINA Technologies, a biotechnology company specializing in the development of nanomedicines, today announces the signing of a partnership agreement with Atlangram for the development of innovative pharmaceutical forms of antibiotics for the targeting of osteoarticular infectious diseases.

16 Dec 2014

Scientists validate oral vaccine delivery system to combat global health threats

Scientists at The Forsyth Institute and Tufts University have succeeded in describing and validating a unique system of oral vaccine delivery using a common bacteria found in the mouth.

16 Dec 2014

Simple assessments can help prevent risk of passing Ebola virus disease from organ donor

While serious infections can be transmitted from donated organs, the risk of passing Ebola virus disease from an organ donor to a recipient is extremely small. In a new editorial published in the American Journal of Transplantation, experts explain how simple assessments of donors can help ensure that the organ supply is safe, while having little impact on the donor pool.

16 Dec 2014

Study provides evidence for presence of enterovirus in pancreatic islets of type 1 diabetic patients

Norwegian scientists with European partners have found evidence for the presence of Enterovirus in pancreatic islets of type 1 diabetic patients. This provides evidence consistent with the theory that a low grade Enteroviral infection in the pancreatic islets contribute to disease progression in humans.

16 Dec 2014

NICE recommends REMICADE, HUMIRA and SIMPONI therapies for patients with ulcerative colitis

The National Institute for Health and Care Excellence (NICE) has issued its Final Appraisal Document (FAD) recommending REMICADE (infliximab), HUMIRA (adalimumab) and SIMPONI (golimumab), within their marketing authorisations, as options for treating moderately to severely active ulcerative colitis (UC) in adults whose disease has responded inadequately to conventional therapy including corticosteroids and mercaptopurine or azathioprine, or who cannot tolerate, or have medical contraindications for, such therapies.

16 Dec 2014

Murdoch University outlines research on antimicrobial resistance at symposium

Murdoch University profiled its strong teaching and research focus around a One Health agenda at a symposium on a looming public health issue, antimicrobial resistance (AMR), on December 8.

16 Dec 2014

Heroin use impacts HIV disease progression

Researchers at Yale and Boston University and their Russian collaborators have found that occasional heroin use by HIV-positive patients may be particularly harmful to the immune system and worsens HIV disease, compared to persistent or no heroin use.

15 Dec 2014

Disease/Infection News

High-dose flu vaccine better than regular flu shot for frail, older adults of long-term care facilities

Study offers insights into mechanisms of bacterial resistance to antimicrobial peptides

R. Geigy Foundation recognizes scientific endeavours in neglected disease research, public health

COUNTDOWN research consortium focuses on neglected tropical diseases

New research finds that more frequent hugs protect people from stress, infection

Scientists discover how certain gut bacteria can protect themselves, others from antibiotics

EGPAF to receive $63 million UNITAID grant to improve early infant diagnosis of HIV programs

Researchers identify 53 existing drugs that may block Ebola virus from entering human cells

New intervention combines social media with behavioral psychology to encourage more HIV testing

Tufts University researchers report that extra vitamin E can protect against pneumonia

DNDi awarded USAID grant to develop new treatments for river blindness, elephantiasis

New study shows that people may inherit intestinal bacteria that cause inflammatory bowel disease

CMC Biologics, OncoSynergy partner to develop novel potential treatment for Ebola

CARLINA, Atlangram partner to develop antibiotics for osteoarticular infectious diseases

Scientists validate oral vaccine delivery system to combat global health threats

Simple assessments can help prevent risk of passing Ebola virus disease from organ donor

Study provides evidence for presence of enterovirus in pancreatic islets of type 1 diabetic patients

NICE recommends REMICADE, HUMIRA and SIMPONI therapies for patients with ulcerative colitis

Murdoch University outlines research on antimicrobial resistance at symposium

Heroin use impacts HIV disease progression

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News